Absolute neutrophil count (ANC) >= 1500/mm^3 [clinicaltrials_resource:096652572c212763fbe49e478305db41]
eligibility for clinicaltrials:NCT01932697 [clinicaltrials_resource:03a3899507de29024aaa33bf957f1510]eligibility for clinicaltrials:NCT02337426 [clinicaltrials_resource:0881fc6a322ab92f857c06e708935918]eligibility for clinicaltrials:NCT02126527 [clinicaltrials_resource:0f8f7c40937a580901768e3c615db6dc]eligibility for clinicaltrials:NCT01606241 [clinicaltrials_resource:1fc38d70fca8eb06f5d1c24e88e8808b]eligibility for clinicaltrials:NCT00049127 [clinicaltrials_resource:22f90324d3f546160a14865aad267bc5]eligibility for clinicaltrials:NCT01749397 [clinicaltrials_resource:25dbb1df61d7ca654965c99197dadc36]eligibility for clinicaltrials:NCT02063698 [clinicaltrials_resource:2f024828e3f47418a28d1013a70c0cd2]eligibility for clinicaltrials:NCT02020707 [clinicaltrials_resource:316140ecc1c7ed206368feb0db73383c]eligibility for clinicaltrials:NCT01957995 [clinicaltrials_resource:3bbd79e7992b957a07a58c5d3fbae792]eligibility for clinicaltrials:NCT02178436 [clinicaltrials_resource:44196700fc5d3f5affbe1b7fc4e3bd7c]eligibility for clinicaltrials:NCT02457910 [clinicaltrials_resource:4abf180ba9e729c901309e62ab1a3978]eligibility for clinicaltrials:NCT00039104 [clinicaltrials_resource:77c53c89f43ee6e36f14d38aaf9f962b]eligibility for clinicaltrials:NCT02265341 [clinicaltrials_resource:863adb13b66372650af12f006c2d6ccc]eligibility for clinicaltrials:NCT00077441 [clinicaltrials_resource:89d0dd1b91b4859c1251b809005cca1b]eligibility for clinicaltrials:NCT01632332 [clinicaltrials_resource:a8b574d8916f0f471d59f677d9aacbf1]eligibility for clinicaltrials:NCT02120222 [clinicaltrials_resource:b51fd2d0ceccfdc384eeb97b2485b80b]eligibility for clinicaltrials:NCT02219789 [clinicaltrials_resource:b5828fe30319eee06c1aae385e83205b]eligibility for clinicaltrials:NCT01880528 [clinicaltrials_resource:baeff4471f8754b1141fe2ca1a6b7db2]eligibility for clinicaltrials:NCT02283658 [clinicaltrials_resource:c30235610d1576973ffe48fd31c013e6]eligibility for clinicaltrials:NCT01010126 [clinicaltrials_resource:c38442d2463d67cc244d3f31b160c28e]eligibility for clinicaltrials:NCT01649258 [clinicaltrials_resource:cb6b754d130b722adb59284459597c1f]eligibility for clinicaltrials:NCT00096109 [clinicaltrials_resource:d65a9cc6c9d8085750ada5ea5135ee18]eligibility for clinicaltrials:NCT00005970 [clinicaltrials_resource:dc1fe3a768d05147ec3c5d12eab1a4a9]eligibility for clinicaltrials:NCT02393690 [clinicaltrials_resource:e11c0672734b39c2c2cebd2cf55d16a8]eligibility for clinicaltrials:NCT02049593 [clinicaltrials_resource:e6b76b0953cab75aab7715f5fa879a3e]eligibility for clinicaltrials:NCT02414646 [clinicaltrials_resource:eeeaff6c564d53520491381f07038c0c]eligibility for clinicaltrials:NCT01873833 [clinicaltrials_resource:f393f672d4e0c776d58d733a911c82d9]eligibility for clinicaltrials:NCT02320292 [clinicaltrials_resource:f755cbfe3d3689ca4b08573df0db75ce]eligibility for clinicaltrials:NCT00055757 [clinicaltrials_resource:f80b6b261e74b6486946e897e05d198d]eligibility for clinicaltrials:NCT02401347 [clinicaltrials_resource:fec5fe4962cc6a0fa84520a7e5c1b9f4]eligibility for clinicaltrials:NCT02281279 [clinicaltrials_resource:ffad6b197c7b5c943417d5850e542d6e]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01932697 [clinicaltrials_resource:03a3899507de29024aaa33bf957f1510]eligibility for clinicaltrials:NCT01145508 [clinicaltrials_resource:05896916fb79370653c428a0d5fe0e4f]eligibility for clinicaltrials:NCT02337426 [clinicaltrials_resource:0881fc6a322ab92f857c06e708935918]eligibility for clinicaltrials:NCT02126527 [clinicaltrials_resource:0f8f7c40937a580901768e3c615db6dc]eligibility for clinicaltrials:NCT01606241 [clinicaltrials_resource:1fc38d70fca8eb06f5d1c24e88e8808b]eligibility for clinicaltrials:NCT00049127 [clinicaltrials_resource:22f90324d3f546160a14865aad267bc5]eligibility for clinicaltrials:NCT01749397 [clinicaltrials_resource:25dbb1df61d7ca654965c99197dadc36]eligibility for clinicaltrials:NCT02063698 [clinicaltrials_resource:2f024828e3f47418a28d1013a70c0cd2]eligibility for clinicaltrials:NCT02020707 [clinicaltrials_resource:316140ecc1c7ed206368feb0db73383c]eligibility for clinicaltrials:NCT01957995 [clinicaltrials_resource:3bbd79e7992b957a07a58c5d3fbae792]eligibility for clinicaltrials:NCT02178436 [clinicaltrials_resource:44196700fc5d3f5affbe1b7fc4e3bd7c]eligibility for clinicaltrials:NCT02457910 [clinicaltrials_resource:4abf180ba9e729c901309e62ab1a3978]eligibility for clinicaltrials:NCT02201992 [clinicaltrials_resource:598aae8408ec6074bd4e8fce4cba40dd]eligibility for clinicaltrials:NCT01471964 [clinicaltrials_resource:6240c8651108b0ef45dba0e315d96020]eligibility for clinicaltrials:NCT00588770 [clinicaltrials_resource:755a28a299a1e938f3c9981bf40fc033]eligibility for clinicaltrials:NCT00039104 [clinicaltrials_resource:77c53c89f43ee6e36f14d38aaf9f962b]eligibility for clinicaltrials:NCT02412670 [clinicaltrials_resource:83c4dfbcc25c9c7bf00b8756641803cc]eligibility for clinicaltrials:NCT02265341 [clinicaltrials_resource:863adb13b66372650af12f006c2d6ccc]eligibility for clinicaltrials:NCT00077441 [clinicaltrials_resource:89d0dd1b91b4859c1251b809005cca1b]eligibility for clinicaltrials:NCT00033618 [clinicaltrials_resource:8a3d6b71ff0f2064176f51629d536ae2]eligibility for clinicaltrials:NCT01632332 [clinicaltrials_resource:a8b574d8916f0f471d59f677d9aacbf1]eligibility for clinicaltrials:NCT00976677 [clinicaltrials_resource:af7acb9d534b2f1720e6cf5c2637b097]eligibility for clinicaltrials:NCT02120222 [clinicaltrials_resource:b51fd2d0ceccfdc384eeb97b2485b80b]eligibility for clinicaltrials:NCT02219789 [clinicaltrials_resource:b5828fe30319eee06c1aae385e83205b]eligibility for clinicaltrials:NCT01880528 [clinicaltrials_resource:baeff4471f8754b1141fe2ca1a6b7db2]eligibility for clinicaltrials:NCT02283658 [clinicaltrials_resource:c30235610d1576973ffe48fd31c013e6]eligibility for clinicaltrials:NCT01010126 [clinicaltrials_resource:c38442d2463d67cc244d3f31b160c28e]eligibility for clinicaltrials:NCT01649258 [clinicaltrials_resource:cb6b754d130b722adb59284459597c1f]eligibility for clinicaltrials:NCT00096109 [clinicaltrials_resource:d65a9cc6c9d8085750ada5ea5135ee18]eligibility for clinicaltrials:NCT00005970 [clinicaltrials_resource:dc1fe3a768d05147ec3c5d12eab1a4a9]eligibility for clinicaltrials:NCT02393690 [clinicaltrials_resource:e11c0672734b39c2c2cebd2cf55d16a8]eligibility for clinicaltrials:NCT02049593 [clinicaltrials_resource:e6b76b0953cab75aab7715f5fa879a3e]eligibility for clinicaltrials:NCT02414646 [clinicaltrials_resource:eeeaff6c564d53520491381f07038c0c]eligibility for clinicaltrials:NCT01873833 [clinicaltrials_resource:f393f672d4e0c776d58d733a911c82d9]eligibility for clinicaltrials:NCT02320292 [clinicaltrials_resource:f755cbfe3d3689ca4b08573df0db75ce]eligibility for clinicaltrials:NCT00055757 [clinicaltrials_resource:f80b6b261e74b6486946e897e05d198d]eligibility for clinicaltrials:NCT02401347 [clinicaltrials_resource:fec5fe4962cc6a0fa84520a7e5c1b9f4]eligibility for clinicaltrials:NCT02281279 [clinicaltrials_resource:ffad6b197c7b5c943417d5850e542d6e]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Absolute neutrophil count (ANC) >= 1500/mm^3 [clinicaltrials_resource:096652572c212763fbe49e478305db41]
Bio2RDF identifier
096652572c212763fbe49e478305db41
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:096652572c212763fbe49e478305db41
identifier
clinicaltrials_resource:096652572c212763fbe49e478305db41
title
Absolute neutrophil count (ANC) >= 1500/mm^3
@en
type
label
Absolute neutrophil count (ANC ...... 652572c212763fbe49e478305db41]
@en